Abstract
• Background: Fluoroquinolones have a strong affinity with melanin, and their ocular effects have been reevaluated. Norfloxacin, one of the fluoroquinolones, has broad-spectrum activity against aerobic gram-positive and gram-negative bacteria. We examined the retinal toxicity and intraocular pharmacokinetics of intravitreal norfloxacin in rabbits. • Methods: Twenty-three albino and 23 pigmented rabbits were divided into three groups to evaluate retinal toxicity and two groups to investigate the intraocular pharmacokinetics. Each of these five groups was further divided into two subgroups (albino rabbits and pigmented rabbits). • Results: With 500 Etg norfloxacin, the oscillatory potential of the electroretinogram was transiently and selectively deteriorated in albino and pigmented rabbits, whereas the electroretinogram remained unchanged with 50 μg in pigmented rabbits. No changes were observed in the visual evoked potential or on histology of the retina 7 days after an intravitreal injection of 50 or 500 ltg norfloxacin. The electroretinogram and the retinal histology became abnormal 7 days after four intravitreal injections of 500 μg norfloxacin at 7-day intervals. As regards the intraocular pharmacokinetics after an intravitreal injection, the norfloxacin concentration in the chorioretina was as high as that in the vitreous 3 h after injection and was much higher than that in the vitreous 7 days after injection. Similar results were obtained after multiple injections. • Conclusion: These results indicate a high concentration of norfloxacin in the melanin-containing ocular tissues.
Similar content being viewed by others
References
Bernstein H, Zvaifler N, Rubin M, Mansour AM (1963) The ocular deposition of chloroquine. Invest Ophthalmol 2:384–392
Campochiaro PA, Conway BP (1991) Aminoglycoside toxicity. A survey of retinal specialists. Implications for ocular use. Arch Ophthalmol 109:946–950
Davis RM, Rowsey JJ, Jensen HG (1987) Anterior limbal approach to vitrectomy for the surgical management of infectious endophthalmitis. Ophthalmic Surg 18:683–686
Fukuda M, Sasaki K (1990) Changes in the antibacterial activity of melanin-bound drugs. Ophthalmic Res 22:123–127
Fukuda M, Sasaki K (1993) Intraocular penetration of norfloxacin into the pigmented rabbit eye. (Japanease) Atarashii Ganka 10:431–434
Heynen H, Wachtmeister L, Norren D van (1985) Origin of the oscillatory potentials in the primate retina. Vision Res 25:1365–1373
Huber-Spitzy VN, Czejka M, Georgiew L, Arocker-Mettinger E, Grabner G (1992) Penetration of norfloxacin into the aqueous humor of the human eye. Invest Ophthalmol Vis Sci 33:1723–1726
Ito A, Hirai K, Inoue H, Koga H, Suzue S, Irikura T, Mitsuhashi S (1980) In vitro antibacterial activity of AM715, a new nalidixic acid analog. Antimicrob Agents Chemother 17:103–108
Kawaguchi H, Yonemura D, Kawasaki K, Yanagida T (1980) Selective suppression of retinal oscillatory potential by some ω-amino acids and its release by their antagonists in human and rabbit in vitro. J Jpn Ophthalmol Soc 84:135–141
Korenbrot JT, Fernald RD (1989) Circadian rhythm and light regulate opsin mRNA in rod photoreceptors. Nature 337:454–457
Lawwill T (1972) Practical rabbit electroretinography. Am J Ophthalmol 74:135–141
Mochizuki K, Torisaki M, Wakabayashi K (1991) Effects of vancomycin and ofloxacin on rabbit ERG in vivo. Jpn J Ophthalmol 35:435–445
Nishino T, Tanaka M, Kawabata S, Yabu C, Yamanaka K, Tanino T (1984) Bacteriological evaluation of DL-8280, a new synthetic antimicrobial agent. Chemotherapy 32:62–83
Ooishi M, Nagai S (1984) Fundamental and clinical studies of DL-8280 in ophthalmology. Chemotherapy 32 [Suppl 1]: 1050–1055
Ooishi M, Miyao M, Sakaue F, Tazawa H, Oomomo A (1991) Intraocular penetration of norfloxacin eye drops. Acta Med Biol 39:67–73
Oomomo A (1991) Intravitreal injection of norfloxacin or ofloxacin. I. Ocular pharmacokinetics. (Japanease) Atarashii Ganka 8:291–295
Oomomo A (1991) Intravitreal injection of norfloxacin or ofloxacin. II. Retinal toxicity. (Japanease) Atarashii Ganka 8:651–654
Peyman GA, Schulman JA (1989) Intravitreal drug therapy. Jpn J Ophthalmol 33:392–404
Sakai H, Komatsu M, Torisaki M, Mochizuki K, Okayama Y, Kitano K, Kawasaki K (1991) Effects of norfloxacin on in vitro rabbit ERG. (Japanease) Atarashii Ganka 8:929–932
Sakai H, Mochizuki K, Torisaki M (1993) Effects of lomefloxacin on the rabbit retina. J Jpn Ophthalmol Soc 97:812–819
Smith JT, Lewin CS (1988) Antibacterial activities. In: Andriole VT (ed) The quinolones. Harcourt Brace Jovanovich, London, pp 32–44
Stern GA, Engel HM, Driebe WT (1989) The treatment of postoperative endophthalmitis. Results of differing approaches to treatment. Ophthalmology 96:62–67
Tsuji A, Sato H, Kume Y, Tamai I, Okezaki E, Nagata O, Kato H (1988) Inhibitory effects of quinolone antibacterial agents on γ-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob Agents Chemother 32:190–194
Wiedemann B (1991) Mechanism of action of norfloxacin. Chibret Int J Ophthalmol 8:15–17
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mochizuki, K., Higashide, T., Torisaki, M. et al. Effects of norfloxacin on the retina in rabbits. Graefe's Arch Clin Exp Ophthalmol 233, 173–180 (1995). https://doi.org/10.1007/BF00166611
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00166611